Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, today announced that the US ...

U.S. home prices climbed 0.2% month over month in November on a seasonally adjusted basis, slightly smaller than October’s 0.3% monthly increase. That’s according to a new report from Redfin, the real ...

LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

LEXINGTON, Mass., December 23, 2025--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer ...

WESTMINSTER, Colo., Dec. 23, 2025 /PRNewswire/ -- Representatives from the Weed Science Society of America (WSSA) are supporting a $700 million Regenerative Pilot Project announced this month by the U ...

After a half-century immersed in the world of trade, customs broker Amy Magnus thought she’d seen it all, navigating ...

Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...

Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand ...

It was scary because the U.S. stock market plunged to several historic drops on worries about everything from President ...

Some U. companies are hedging their bets on the Supreme Court case against President Donald Trump's sweeping emergency ...

Novo Nordisk secured U. regulatory approval for its weight-loss pill, ​giving the Danish drugmaker a shot at reclaiming ...